欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  PI3K/Akt/mTOR  /  PDK  /  MP7

CAS No.: 1001409-50-2

MP7 Catalog No. CSN17379

Synonyms: PDK1 inhibitor

PDK1 inhibitor is a potent and selective inhibitor of PDK1 with potential as anticancer agent.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT02430363GlioblastomaPhase 1 Phase 2UnknownJune 2018United States, Massachusetts ... more >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Belgium UCL- Cliniques Universitaires Saint Luc Brussels, Belgium Germany St Johannes Hospital Duisburg, Germany, 47166 Italy Spedali Civili di Brescia Brescia, Italy IRCCS San Raffaele Milan, Italy Poland Lower-Silesian Oncology Centre Wroclaw, Lower-Silesian, Poland, 53413 Russian Federation Pavlov State Medical University St. Petersburg, Russian Federation, 197089 Spain Hospital Universitario Germans Trias I Pujol Barcelona,, Spain Switzerland Universitätsklinik für Frauenheilkunde Bern, Switzerland Ukraine Regional Cancer Center Dnepropetrovsk, Ukraine, 49000 National Institute of Cancer Kiev, Ukraine, 03035 United Kingdom Royal Victoria Hospital Belfast, Ulster, United Kingdom, BT12 6BA Collapse <<

实验方案

技术信息

CAS号 1001409-50-2 储存条件
分子式 C28H22F2N4O4 运输 蓝冰
分子量 516.50 别名 PDK1 inhibitor

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们